Genetic Engineering & Biotechnology News has issued its list of top 10 U.S. biopharma clusters based on parameters such as patents applied for  and awarded, venture capital funding, National Institutes of Health (NIH) funding, lab space, and number of jobs. Leading the list are the San Fran- cisco Bay Area, Boston/Cambridge, Mass. and san Diego. While the San Francisco region topped Boston/Cambridge by some 500 patents—3,492 and 2,908, respectively—it reportedly lost out “to the Red sox region in NIH grants ($119.8 million)”—Boston/Cambridge garnered $201.4 million. And, as to numbers of jobs in this sector, “it depends who you believe. California’s economic Development Department lists 110,337 Bay Area ‘life sciences’ jobs in the latest tally (Q1 2013), while a recently released report showed only 47,019” as compared with Boston/Cambridge’s 55,462 jobs. Those regions closing out the list are Chicago—10, Los Angeles—nine, and Raleigh-Durham, North Carolina (including Research Triangle Park)— eight. See GenEngNews.com, March 10, 2014.